Organon & Co. (OGN) Stock Price

OGNStock
$13.76+46.70%52W
Market Cap$3.61B
P/E19.32x
PEG Ratio—
Div yield9.86%
Beta1.50

OGN Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)48.26%
Price vs S&P 500 (4W)1.91%
VGM Score54.25
P/E Ratio (Annual)19.32x
Indicated Dividend Yield (Annual)9.86%

OGN Earnings Surprise History

QuarterReport dateEPS estimateEPS actualSurprise
Q2 2026$1.07$0.85-20.56%(-$0.22)
Q1 2026$0.85$0.71-16.82%(-$0.14)
Q4 2025$0.73$0.63-13.34%(-$0.10)
Q3 2025$0.93$1.01+8.46%(+$0.08)
Q2 2025$0.94$1.00+6.36%(+$0.06)

OGN Analyst Recommendations

Jun 2026
Jul 2026
Aug 2026
Sep 2026
2.46
2.46
2.46
2.46

Industry Peers — Pharmaceuticals(574)

SymbolValue ScoreGrowth ScoreMomentum ScoreP/S Ratio (TTM)Revenue Growth TTM (YoY)Gross Margin (TTM)EPS Growth (5Y)Price
OGNOrganon & Co.
BFA0.6x-2.5%52.7%-39.1%$13.76
LLYEli Lilly & Co.DBA14.9x49.6%83.4%27.6%$1257.03
JNJJohnson & JohnsonDCB6.2x7.8%67.7%14.9%$255.56
ABBVABBVIE INC.DCA7.8x10.4%72.8%-2.9%$285.42
MRKMerck & Co., Inc.DCA5.4x4.6%77.3%21.2%$145.95
NVSNovartis AGCCB4.9x3.3%75.0%15.3%$150.62
AZNAstraZeneca PLCCBB4.3x8.6%81.3%21.9%$165.41
ABTAbbott LaboratoriesCCB3.9x8.1%56.8%8.2%$104.89
NVONovo-Nordisk A/SBCC3.5x5.6%80.7%20.7%$38.83
PFEPfizer Inc.CDA2.6x-0.2%74.7%-3.5%$29.58
VRTXVertex Pharmaceuticals IncDCB10.1x10.2%86.0%8.3%$499.74

About Organon & Co.

Organon & Co is a pharmaceutical company focused on women's health, biosimilars, and established brand medications. The majority of revenue comes from established brands, with geographic concentration in Europe and Canada, followed by the United States and Asia Pacific.